New HIV drug shows ‘unprecedented’ results
aids | biomedical | biotech | biotechnology | hiv | pharmaceutical
A new category of drug has shown promising results for HIV/AIDS patients who failed to respond to other treatments, a study to be shows. Especially when combined with other medications, raltegravir — the first in a new class of anti-retroviral drugs called integrase inhibitors — dramatically reduced the presence of the HIV virus and boosted immunity [...]
» full article | source